Paper Details
- Home
- Paper Details
Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease.
Author: BenwellK, CliffeI A, DourishC T, GillespieR J, KnightA R, LerpiniereJ, MisraA, PrattR M, RevellD, UptonR, WeissS M
Original Abstract of the Article :
During a program to investigate the biochemical basis of side effects associated with the antimalarial drug mefloquine, the authors made the unexpected discovery that the (-)-(R,S)-enantiomer of the drug is a potent adenosine A2A receptor antagonist. Although the compound was ineffective in in vivo ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1212/01.wnl.0000095581.20961.7d
データ提供：米国国立医学図書館（NLM）
Targeting Adenosine A2A Receptors: A Novel Approach for Parkinson's Disease
This is an exciting study that ventures into the realm of [neurology] and explores the potential of [drug development] for treating Parkinson's disease. Imagine a desert where the sand represents the complexities of Parkinson's and the researchers are digging for a hidden oasis – a new treatment. The researchers discovered that [drug] could be a potent [drug target] for Parkinson's disease. The study provides a strong foundation for the development of new drugs that could offer relief to those struggling with this debilitating condition.
Adenosine A2A Antagonists: A Promising Avenue for Parkinson's Treatment
The researchers have developed a novel class of drugs that effectively block adenosine A2A receptors. These drugs showed promising results in animal models, suggesting their potential effectiveness in treating Parkinson's disease. The study highlights the importance of exploring new drug targets for Parkinson's disease and could pave the way for new treatment options.
Understanding Parkinson's: The Role of Adenosine A2A Receptors
This research sheds light on the complex interplay between neurotransmitters and their receptors in Parkinson's disease. It is crucial to maintain a healthy lifestyle, consult with a medical professional, and explore treatment options available to manage Parkinson's disease. This research is a beacon of hope in the vast desert of neurological disorders, offering potential pathways for future treatments.
Dr. Camel's Conclusion
This study has unearthed promising new avenues for treating Parkinson's disease by targeting adenosine A2A receptors. The discovery of these novel antagonists provides a glimmer of hope for developing more effective treatments in the future. Like a camel navigating the vast desert, researchers are tirelessly seeking solutions for this challenging disease, offering hope and a better future for those affected.
Date :
- Date Completed 2004-02-11
- Date Revised 2019-12-10
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.